CD8A and neoplasm: Upon the addition of ICM, we propose that the tumor-specific CD8+ T cells no longer required assistance from CD4+ T cells and NK cells to mediate the antitumor effect and that ICM was providing (or blocking) the signals to CD8+ T cells required to promote an optimal effector response.